fbpx
 
HomeCategory

FDA

FDA_branded_1200x675_220513

“Q&A with FDA” provides engaging conversation and discussion about the latest regulatory topics. In this podcast series, FDA’s Division of Drug Information will answer some of the most commonly asked questions received by FDA. Perhaps you have had the same questions but never asked. Dr. Theresa Michele from the Office of Nonprescription Drugs within the...

The Essential Role of Compliance in Drug Compounding: Insights and Updates from FDA’s 2023 Report

The U.S. Food and Drug Administration’s Office of Compliance has recently unveiled its Annual Report for Fiscal Year 2023, spotlighting significant strides and ongoing efforts in the realm of drug compounding and the implementation of the Drug Quality and Security Act (DQSA). As we mark nearly a decade since the enactment of DQSA, the emphasis...